Veralto Corporation (VLTO Quick QuoteVLTO - Free Report) is currently benefiting from its leadership in Water Quality and PQI segments, strategic acquisitions and growing dividends.

The companyrecently reported impressive fourth-quarter 2024 results, wherein earnings and revenues beat the Zacks Consensus Estimate. Quarterly EPS was 95 cents, which outpaced the Zacks Consensus Estimate by 8% and gained 9.2% on a year-over-year basis. Total revenues of $1.35 billion beat the consensus mark by a slight margin and increased 4.4% from the year-ago quarter.

How is VLTO Faring?

VLTO’s leadership in the Water Quality segment positions it to capitalize on robust growth opportunities in the United States. The industrial and municipal verticals serve as key drivers of this growth. In the industrial vertical, the CHIPS Act of 2022 provides a significant tailwind through semiconductor manufacturing grants, research investments and tax credits. Additionally, the global increase in semiconductor production enhances VLTO’s prospects, as ultra-pure water is critical for semiconductor manufacturing.

While the semiconductor industry has faced recent challenges, the long-term outlook remains favorable, driven by rising demand for digital tools, AI and autonomous technologies, which necessitate more semiconductor production. In the municipal vertical, increased U.S. government funding to address the country’s water infrastructure challenges offers a strong growth catalyst. This support is expected to boost investments in upgrading and modernizing water systems, further driving demand for VLTO’s solutions. The company’s WC revenues grew 3.4% year over year in 2024.

VLTO has established itself as a trusted leader in the Product Quality and Inspection (PQI) segment, serving the major consumer-packaged goods (CPG), life sciences, and pharmaceutical companies. The Marketing & Coding (M&C) sub-segment is the largest contributor to PQI’s revenues, reflecting its critical role in driving industry growth. M&C has become indispensable for CPG and pharmaceutical companies in a digital-first world. In the pharmaceutical sector, coding ensures regulatory compliance, facilitates accurate data management and enhances communication with healthcare professionals and patients.

These capabilities are vital as the industry increasingly relies on digital solutions for efficiency and transparency. For CPG companies, M&C integrates supply chain operations with consumer insights, enabling quick adaptation to market trends and fostering stronger customer engagement. This innovation helps businesses stay competitive in an ever-evolving landscape. By addressing these critical needs, VLTO empowers its clients to innovate, build stronger customer relationships and maintain a competitive edge. This robust positioning within high-growth industries highlights VLTO’s potential for sustained success, making it an appealing investment opportunity for stakeholders seeking exposure to innovative and resilient markets.

The company’s PQI revenues grew 3.7% year over year in 2024. The recent acquisition of TraceGains strengthened the segment by adding advanced digital workflow solutions, particularly for the food and beverage industry.

Veralto’s Trojan Technologies is set to strengthen its European customer support and service excellence through the planned acquisition of AQUAFIDES, expected to be finalized in the second quarter of 2025. This acquisition will also broaden VLTO’s UV treatment portfolio with

VLTO’s commitment to shareholder returns, despite being a recent entrant to the stock market, makes it an appealing investment option. Since its NYSE listing in late 2024, the company has consistently paid a quarterly dividend of 9 cents, demonstrating financial discipline. The recent 22% dividend increase to 11 cents per share further underscores VLTO’s confidence in its financial strength and growth prospects. This early adoption of a progressive dividend policy is particularly significant for a newly listed company, as it signals stability, profitability and a shareholder-friendly approach.

Some Risks

VLTO faces competitive pressure from established players and new entrants in the PQI and digital workflow solution sectors. These competitors may offer similar or superior technologies at more competitive prices, limiting VLTO’s market share and growth potential. As the industry becomes more crowded, VLTO could struggle to differentiate its offerings, which might lead to reduced customer loyalty or price compression. Competitive pressure may hinder VLTO’s ability to maintain strong margins,ultimately affecting profitability and investor confidence.

For risk-averse investors, the potential integration risks associated with VLTO’s acquisition of TraceGains could be a deterrent. The uncertainty surrounding the integration process, such as potential operational disruptions, increased costs, or delays in realizing synergies, increases risk. If the integration faces challenges, it could negatively impact VLTO’s short-term profitability and growth projections, creating volatility.

Earnings Snapshots

Gartner, Inc. (IT Quick QuoteIT - Free Report) reported better-than-expected fourth-quarter 2024 results. IT’s adjusted earnings per share of $5.6 beat the Zacks Consensus Estimate by 69.3% and increased 79.3% from the year-ago quarter. Revenues of $1.7 billion surpassed the consensus estimate by 1.8% and improved 8.2% year over year.

Broadridge Financial Solutions, Inc. (BR Quick QuoteBR - Free Report) posted impressive second-quarter fiscal 2025 results.

BR’s adjusted earnings of $1.6 per share outpaced the consensus mark by 12.2% and surged 69.6% from the year-ago quarter. Total revenues of $1.6 billion surpassed the consensus mark by 3% and rose 12.8% year over year.

WM (WM Quick QuoteWM - Free Report) reported mixed fourth-quarter 2024 results. WM’s quarterly adjusted earnings of $1.7 per share missed the consensus mark by 5% and declined 2.3% year over year. Total revenues of $5.9 billion surpassed the consensus mark by a slight margin and grew 13% from the year-ago quarter.